Hansoh Pharmaceutical Group Co Limited/ADR (HNSPF)

OTC: HNSPF · CIK 0002073669 · United States

Every official Hansoh Pharmaceutical Group Co Limited/ADR filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Open HNSPF filings

Hansoh Pharmaceutical Group Co Limited/ADR documents

Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2026HNSPF 10-K 2026: annual report for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2025HNSPF 10-K 2025: annual report for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2024HNSPF 10-K 2024: annual report for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2023HNSPF 10-K 2023: annual report for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2022HNSPF 10-K 2022: annual report for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2026HNSPF 10-Q 2026: quarterly report for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2025HNSPF 10-Q 2025: quarterly report for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2024HNSPF 10-Q 2024: quarterly report for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2023HNSPF 10-Q 2023: quarterly report for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2022HNSPF 10-Q 2022: quarterly report for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2026HNSPF 8-K 2026: current report for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2025HNSPF 8-K 2025: current report for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2024HNSPF 8-K 2024: current report for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2023HNSPF 8-K 2023: current report for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2022HNSPF 8-K 2022: current report for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2026HNSPF DEF 14A 2026: proxy statement for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2025HNSPF DEF 14A 2025: proxy statement for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2024HNSPF DEF 14A 2024: proxy statement for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2023HNSPF DEF 14A 2023: proxy statement for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2022HNSPF DEF 14A 2022: proxy statement for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2026HNSPF Form 4 2026: insider trading filing for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2025HNSPF Form 4 2025: insider trading filing for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2024HNSPF Form 4 2024: insider trading filing for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2023HNSPF Form 4 2023: insider trading filing for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2022HNSPF Form 4 2022: insider trading filing for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2026HNSPF S-1 2026: registration statement for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2025HNSPF S-1 2025: registration statement for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2024HNSPF S-1 2024: registration statement for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2023HNSPF S-1 2023: registration statement for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2022HNSPF S-1 2022: registration statement for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2026HNSPF 13F 2026: institutional holdings for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2025HNSPF 13F 2025: institutional holdings for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2024HNSPF 13F 2024: institutional holdings for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2023HNSPF 13F 2023: institutional holdings for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2022HNSPF 13F 2022: institutional holdings for fiscal 2022

More companies